1. Home
  2. RGEN vs DSGX Comparison

RGEN vs DSGX Comparison

Compare RGEN & DSGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • DSGX
  • Stock Information
  • Founded
  • RGEN 1981
  • DSGX 1981
  • Country
  • RGEN United States
  • DSGX Canada
  • Employees
  • RGEN N/A
  • DSGX N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • DSGX Computer Software: Prepackaged Software
  • Sector
  • RGEN Health Care
  • DSGX Technology
  • Exchange
  • RGEN Nasdaq
  • DSGX Nasdaq
  • Market Cap
  • RGEN 7.6B
  • DSGX 9.8B
  • IPO Year
  • RGEN N/A
  • DSGX 1999
  • Fundamental
  • Price
  • RGEN $156.55
  • DSGX $112.54
  • Analyst Decision
  • RGEN Buy
  • DSGX Buy
  • Analyst Count
  • RGEN 12
  • DSGX 11
  • Target Price
  • RGEN $187.44
  • DSGX $117.00
  • AVG Volume (30 Days)
  • RGEN 470.1K
  • DSGX 203.2K
  • Earning Date
  • RGEN 02-19-2025
  • DSGX 03-05-2025
  • Dividend Yield
  • RGEN N/A
  • DSGX N/A
  • EPS Growth
  • RGEN N/A
  • DSGX 20.62
  • EPS
  • RGEN N/A
  • DSGX 1.58
  • Revenue
  • RGEN $633,513,000.00
  • DSGX $631,755,000.00
  • Revenue This Year
  • RGEN $2.28
  • DSGX $15.25
  • Revenue Next Year
  • RGEN $9.88
  • DSGX $11.43
  • P/E Ratio
  • RGEN N/A
  • DSGX $70.84
  • Revenue Growth
  • RGEN N/A
  • DSGX 14.90
  • 52 Week Low
  • RGEN $113.50
  • DSGX $82.88
  • 52 Week High
  • RGEN $211.13
  • DSGX $122.88
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 60.07
  • DSGX 44.29
  • Support Level
  • RGEN $149.15
  • DSGX $109.59
  • Resistance Level
  • RGEN $160.64
  • DSGX $115.58
  • Average True Range (ATR)
  • RGEN 5.96
  • DSGX 1.77
  • MACD
  • RGEN 0.91
  • DSGX -0.46
  • Stochastic Oscillator
  • RGEN 79.57
  • DSGX 46.75

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About DSGX Descartes Systems Group Inc. (The)

Descartes Systems Group provides a software solution that allows users in the shipping industry to communicate with one another. Its core product is the Global Logistics Network, which is best understood as transaction-driven. Descartes charges clients to send/receive messages, data, and documents on the GLN. Customers typically contract for a monthly minimum over a multiyear period. The GLN platform allows Descartes to upsell additional software modules as well, typically provided via a software-as-a-service model.

Share on Social Networks: